Darbepoetin alpha has an anxiolytic and anti-neuroinflammatory effect in male rats

dc.authoridOnal, Deniz/0000-0002-9604-4539
dc.contributor.authorCaliskan, Hasan
dc.contributor.authorOnal, Deniz
dc.contributor.authorNalcaci, Erhan
dc.date.accessioned2025-07-03T21:25:42Z
dc.date.issued2024
dc.departmentBalıkesir Üniversitesi
dc.description.abstractAimsWe aimed to investigate the anxiolytic effect of darbepoetin alpha (DEPO), an erythropoietin derivative, in a neuroinflammation model regarding different behaviors and biological pathways.MethodsForty adult male Wistar albino rats were divided into four groups (control, LPS, DEPO, and DEPO + LPS). The rats were treated with 5 mu g /kg DEPO once a week for four weeks, after which neuroinflammation was induced with 2 mg/kg lipopolysaccharide (LPS). The elevated plus maze, open-field, and light-dark box tests were conducted to assess anxiety levels. Harderian gland secretions were scored via observation. Tumor necrosis factor alpha (TNF-alpha), Interleukin-1-beta (IL-1 beta), brain-derived growth factor (BDNF), serotonin, cortisol, total antioxidant/oxidant (TAS/TOS), and total/free thiol levels were measured in the prefrontal cortex, striatum, and serum.ResultsDEPO had a potent anxiolytic effect on both DEPO and DEPO + LPS groups. Compared to the control group, DEPO administration caused an increase in serotonin and BDNF levels and decreased basal cortisol and TNF-alpha levels in naive rats. IL-1 beta did not alter after DEPO administration in naive rats. Prophylactic DEPO treatment remarkably downregulated cortisol, IL-1 beta, and TNF-alpha in the DEPO + LPS group. In addition, prophylactic DEPO administration significantly attenuated the decrease in serotonin and BDNF levels in the DEPO + LPS group. Furthermore, DEPO ameliorated excessive harderian gland secretion in the DEPO + LPS group. Compared with those in the control group, the free thiol content in the serum increased after DEPO administration. No similar effect was seen in the DEPO + LPS group receiving prophylactic DEPO. TAS showed no difference among all experimental groups. DEPO administration increased TOS and OSI in the serum and prefrontal cortex but not in the striatum. This effect was not seen in the DEPO + LPS group.ConclusionDarbepoetin alpha had an anxiolytic effect on many physiological mechanisms in a neuroinflammation model and naive rats.
dc.description.sponsorshipAnkara University Scientific Research Projects Directorate [19L0230011]
dc.description.sponsorshipThis research was supported by Ankara University Scientific Research Projects Directorate with project number 19L0230011.The presented work received the second prize at the Turkish Physiology Congress in 2023 and congress abstracts were published in Wiley Acta Physiologica.
dc.identifier.doi10.1186/s12865-024-00665-5
dc.identifier.issn1471-2172
dc.identifier.issue1
dc.identifier.pmid39523336
dc.identifier.scopusqualityQ3
dc.identifier.urihttps://doi.org/10.1186/s12865-024-00665-5
dc.identifier.urihttps://hdl.handle.net/20.500.12462/21618
dc.identifier.volume25
dc.identifier.wosWOS:001352385300001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherBmc
dc.relation.ispartofBmc Immunology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250703
dc.subjectAnxiety
dc.subjectDarbepoetin alpha
dc.subjectErythropoietin
dc.subjectNeuroinflammation
dc.titleDarbepoetin alpha has an anxiolytic and anti-neuroinflammatory effect in male rats
dc.typeArticle

Dosyalar